Acta Med. 2007, 50: 51-56

https://doi.org/10.14712/18059694.2017.59

NT-proBNP and Echocardiographic Parameters in Patients with Acute Heart Failure

Radek Pudila, Miloš Tichýb, Rudolf Prausa, Václav Bláhac, Jan Vojáčeka

aCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, 1st Department of Medicine – Division of Cardiology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Institute of Clinical Biochemistry, Hradec Králové, Czech Republic
cUniversity of Defence Brno, Faculty of Military Health Sciences, Hradec Králové, Department of AD Systems, Hradec Králové, Czech Republic

Received November 1, 2006
Accepted January 1, 2007

References

1. Bettencourt P, Frioes F, Azevedo A, Dias P, Pimenta J, Rocha-Goncalves F, Ferreira A. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol. 2004; 93:45–8. <https://doi.org/10.1016/S0167-5273(03)00115-3>
2. Cappellin E, Gatti R, Spinella P, De Palo CB, Woloszczuk W, Maragno I, De Palo EF. Plasma atrial natriuretic peptide (ANP) fragments proANP (1–30) and proANP (31–67) measurements in chronic heart failure: a useful index for heart transplantation? Clin Chim Acta. 2001; 310:49–52. <https://doi.org/10.1016/S0009-8981(01)00520-4>
3. Clerico A, Edmin M. Diagnostic Accuracy and Prognostic Relevance of the Measurement of cardiac Natriuretic Peptides: A Review. Clin Chem. 2004; 6:33–50. <https://doi.org/10.1373/clinchem.2003.024760>
4. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDonagh T, Mair J, Nieminen M, Francis G. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003; 24:1710–8. <https://doi.org/10.1016/S0195-668X(03)00476-7>
5. Daly C, Fox K, Henein M. Natriuretic peptides in the diagnosis of heart disease— first amongst equals? Int J Cardiol. 2002; 84:107–13. <https://doi.org/10.1016/S0167-5273(02)00143-2>
6. Denus S, Pharand C, Williamson D. Brain Natriuretic Peptide in the Management of Heart Failure. Chest 2004; 125: 652–668. <https://doi.org/10.1378/chest.125.2.652>
7. Devereux RB, Koren MJ, deSimone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur. Heart J. 1993; 14: 8–15. <https://doi.org/10.1093/eurheartj/14.suppl_D.8>
8. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal probrain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003; 24:1735–43. <https://doi.org/10.1016/j.ehj.2003.07.005>
9. Guidelines for the evaluation and management of heart failure. Report of the ACC/AHA task force on practice guidelines. J Am Coll Cardiol 1995; 26:1376–98.
10. Hall C. Essential biochemistry and pathophysiology of NT-pro BNP. Eur J Heart Failure 2004; 6: 257–260. <https://doi.org/10.1016/j.ejheart.2003.12.015>
11. Hammemer-Lercher A, Neubauer E, Muller S, Pachinger O, Puschendorf B, Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310:193–197. <https://doi.org/10.1016/S0009-8981(01)00578-2>
12. Ishii J, Nomura M, Ito M, Naruse H, Mori Y, Wang JH, Ishikawa T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Watanabe Y, Hishida H. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 2000; 301:19–30. <https://doi.org/10.1016/S0009-8981(00)00312-0>
13. Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Barlera S, Maggioni AP, Tognoni G, Cohn JN; For the Val-HeFT Investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004; 25:292–9. <https://doi.org/10.1016/j.ehj.2003.10.030>
14. Maisel A, McCord J, Nowak R, Hollander J, Wu A, Duc P, Omland T et al.: Bedside B. type Natriuretic peptide in the emergency Diagnosis of heart failure with reduced or preserved ejection fraction. J AM Coll Cardiol. 2003; 41:2010–7i. <https://doi.org/10.1016/S0735-1097(03)00405-4>
15. Morrison K, Harrison A, Krishnawamy P, Kazanegra R, Clopton P, Maisel A. Utilitity of a Rapid B.-Natriuretic Peptide Assay in Differentiating Congestive Heart Failure from Lung Disease in Patients Presenting With Dyspnea. J Am Coll Cardiol. 2002; 39:202–9. <https://doi.org/10.1016/S0735-1097(01)01744-2>
16. Nieminen M, Bohm M, Cowie M, Drexler H, Filippatos G, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, hodes A, Swedberg K. Exucutive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J. 2005, 26: 384–416.
17. Sahn DJ, DeMaria A, Kisso J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–83. <https://doi.org/10.1161/01.CIR.58.6.1072>
18. Shimizu H, Aono K, Masuta K, Asada H, Misaki A, Teraoka H. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 1999; 285:169–72. <https://doi.org/10.1016/S0009-8981(99)00112-6>
19. Shimizu H, Masuta K, Aono K, Asada H, Sasakura K, Tamaki M, Sugita K, Yamada K. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002; 316: 129–35. <https://doi.org/10.1016/S0009-8981(01)00745-8>
20. Shimizu H, Masuta K, Asada H, Sugita K, Sairenji T. Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 2003; 334: 233–9. <https://doi.org/10.1016/S0009-8981(03)00240-7>
21. Tjeerdsma G, de Boer RA, Boomsma F, van den Berg MP, Pinto YM, van Veldhuisen DJ. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure. Int J Cardiol. 2002; 86: 143–9. <https://doi.org/10.1016/S0167-5273(02)00409-6>
22. Valli N, Georges A, Corcuff JB, Barat JL, Bordenave L. Assessment of brain natriuretic peptide in patients with suspected heart failure: comparison with radionuclide ventriculography data. Clin Chim Acta 2001; 306:19–26. <https://doi.org/10.1016/S0009-8981(01)00388-6>
23. Vorvouri E, Schinkel A, Roelandt J, Boosma F, Sianos G, Bountioukos M, Sozzi F, Rizzelo V, Bax J, Karvounis H, Poldermans D. Screening for the left ventricular dysfunction using a hand-carried cardiac ultrasound device. Eur J Heart Failure 2003; 5:767–774. <https://doi.org/10.1016/S1388-9842(03)00155-7>
24. Yamamoto K, Burnett JC, Jougasaki M et al., Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988–994 <https://doi.org/10.1161/01.HYP.28.6.988>
25. Yu CM, Sanderson JE, Shum IO, Chan S, Yeung LY, Hung YT, Cockram CS, Woo KS. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J. 1996; 17:1694–702. <https://doi.org/10.1093/oxfordjournals.eurheartj.a014753>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive